Menu

Titan Pharmaceuticals, Inc. TTNP

Full chart Compare
Set alert

Price alert · TTNP

All alert types
2.34 0.00 (+0.00%)

Dec 16, 2025, 1:46 PM EST

2.30 Day range 2.69
3.14 52-week range 14.80
YTD
-28.22%
1 year
-55.09%

Revenue & Expenses

Other Income → Expenses: $1.71MExpenses → Selling, General & Admin: $5.55MExpenses → Research & Development: $1.91MGross Profit → Expenses: $184.00KRevenue → Gross Profit: $184.00KNet Loss → Expenses: $5.57MOther Income$1.71MGross Profit$184.00KNet Loss$5.57MExpenses$7.46MSelling, General & Admin$5.55MResearch & Development$1.91MRevenue$184.00K

Latest period ending Dec 31, 2024 · select a line to chart its full history

TTNP annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-4.56M-7.28M-10.23M-9.35M-7.35M
-4.71M-5.57M-10.21M-8.78M-18.24M
-5.23-7.41-15.19-18.00-96.20
TTNP annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
2.83M6.77M3.13M6.33M5.41M
2.92M8.09M4.06M7.99M8.09M
483.00K1.44M2.69M2.86M4.55M
2.44M6.64M1.36M5.14M3.53M
TTNP annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-3.88M-7.09M-8.18M-7.90M-17.20M
-62.00K10.00M4.98M8.84M17.93M
-3.94M3.64M-3.20M919.00K190.00K